Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly
Phase of Trial: Phase III
Latest Information Update: 29 Oct 2018
At a glance
- Drugs Fesoterodine (Primary)
- Indications Urinary incontinence
- Focus Therapeutic Use
- Acronyms URGE
- 05 Jan 2018 Status changed from active, no longer recruiting to completed.
- 17 Feb 2017 Planned End Date changed from 1 May 2016 to 1 Dec 2017.
- 17 Feb 2017 Planned primary completion date changed from 1 May 2016 to 1 Dec 2017.